Week In Review: China Life Science Announces $5 Billion In Deals, A Weekly Record

, , Comments Off on Week In Review: China Life Science Announces $5 Billion In Deals, A Weekly Record

BeiGene will develop a portfolio of Amgen cancer drugs in China. Hangzhou Tigermed (SHZ: 300347), a clinical CRO, has been approved to stage an IPO on the Hong Kong exchange that could raise up to …
( read original story …)